Moreover, we employed Gene Set Enrichment Analysis (GSEA) to investigate the expression of IL8RB in prostate cancer (PRAD), and ELISA to verify the findings in patients recruited from our centers. The gene discussed is CXCR2; the disease is prostate adenocarcinoma.